Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: …
Over the last 12 months, insiders at Ventas, Inc. have bought $0 and sold $27.31M worth of Ventas, Inc. stock.
On average, over the past 5 years, insiders at Ventas, Inc. have bought $0 and sold $10.81M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $580,101 was made by CROCKER DOUGLAS II (director) on 2013‑12‑10.
2024-10-30 | Sale | Chairman and CEO | 34,085 0.0082% | $66.67 | $2.27M | -3.05% | ||
2024-10-29 | Sale | Chairman and CEO | 121,248 0.0293% | $66.17 | $8.02M | -2.39% | ||
2024-10-25 | Sale | Chairman and CEO | 6,004 0.0015% | $66.11 | $396,930 | 0.00% | ||
2024-10-24 | Sale | Chairman and CEO | 74,763 0.0184% | $66.10 | $4.94M | 0.00% | ||
2024-09-11 | Sale | EVP OM&R-Ventas/Pres&CEO-LHS | 1,500 0.0004% | $65.27 | $97,905 | -0.41% | ||
2024-09-10 | Sale | EVP OM&R-Ventas/Pres&CEO-LHS | 6,000 0.0015% | $64.99 | $389,942 | -1.17% | ||
2024-09-09 | Sale | Chairman and CEO | 22,690 0.0055% | $63.81 | $1.45M | +0.08% | ||
2024-09-06 | Sale | Chairman and CEO | 8,154 0.002% | $63.04 | $514,021 | +2.15% | ||
2024-09-05 | Sale | Chairman and CEO | 6,827 0.0017% | $63.20 | $431,439 | +2.21% | ||
2024-09-04 | Sale | Chairman and CEO | 3,617 0.0009% | $63.05 | $228,046 | +2.64% | ||
2024-08-27 | Sale | Chairman and CEO | 38,434 0.0093% | $60.14 | $2.31M | +6.35% | ||
2024-08-27 | Sale | EVP OM&R-Ventas/Pres&CEO-LHS | 7,125 0.0017% | $60.16 | $428,610 | +6.35% | ||
2024-08-26 | Sale | Chairman and CEO | 2,854 0.0007% | $60.02 | $171,286 | +6.95% | ||
2024-08-26 | Sale | EVP OM&R-Ventas/Pres&CEO-LHS | 375 <0.0001% | $60.01 | $22,504 | +6.95% | ||
2024-08-08 | Sale | EVP and CFO | 20,000 0.0048% | $58.87 | $1.18M | +7.88% | ||
2024-08-06 | Sale | Chairman and CEO | 40,079 0.0099% | $57.29 | $2.3M | +10.93% | ||
2024-08-05 | Sale | Chairman and CEO | 986 0.0002% | $57.03 | $56,234 | +13.60% | ||
2024-08-02 | Sale | Chairman and CEO | 229 <0.0001% | $57.00 | $13,053 | +12.11% | ||
2024-08-01 | Sale | Pres&CEO-LHS/EVP Office-Ventas | 3,784 0.0009% | $55.24 | $209,019 | +14.32% | ||
2024-07-31 | Sale | Pres&CEO-LHS/EVP Office-Ventas | 3,028 0.0008% | $55.09 | $166,812 | +0.38% |
CROCKER DOUGLAS II | director | 104164 0.0248% | $64.37 | 1 | 4 | +14.31% |
GILCHRIST RICHARD I | director | 35270 0.0084% | $64.37 | 1 | 1 | +16.31% |
THEOBALD THOMAS C | director | 16949 0.004% | $64.37 | 2 | 3 | +22.63% |
The Vanguard Group | $2.79B | 15.84 | 64.11M | +0.18% | +$5.14M | 0.05 | |
BlackRock | $1.87B | 10.59 | 42.88M | +2.26% | +$41.2M | 0.04 | |
State Street | $1.17B | 6.56 | 26.54M | -6.9% | -$86.53M | 0.05 | |
Fidelity Investments | $1.05B | 5.97 | 24.16M | +4.81% | +$48.26M | 0.07 | |
JPMorgan Chase | $1.02B | 5.81 | 23.52M | +17.48% | +$152.37M | 0.09 |